<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35412419</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2162-397X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Adipocyte</Title>
          <ISOAbbreviation>Adipocyte</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Integrative analyses of hub genes and their association with immune infiltration in adipose tissue, liver tissue and skeletal muscle of obese patients after bariatric surgery.</ArticleTitle>
        <Pagination>
          <StartPage>190</StartPage>
          <EndPage>201</EndPage>
          <MedlinePgn>190-201</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21623945.2022.2060059</ELocationID>
        <Abstract>
          <AbstractText>Bariatric surgery (BS) is an effective treatment for obesity. Adipose tissue, liver tissue and skeletal muscle are important metabolic tissues. This study investigated hub genes and their association with immune infiltration in these metabolic tissues of obese patients after BS by bioinformatic analysis with Gene Expression Omnibus datasets. Differentially expressed genes (DEGs) were identified, and a protein-protein interaction network was constructed to identify hub genes. As a result, 121 common DEGs were identified and mainly enriched in cytokine-cytokine receptor interactions, chemokine signaling pathway, neutrophil activation and immune responses. Immune cell infiltration analysis showed that the abundance of M1 macrophages was significantly lower in adipose and liver tissue after BS (p&lt;0.05). Ten hub genes (TYROBP, TLR8, FGR, NCF2, HCK, CCL2, LAPTM5, MNDA and S100A9) that were all downregulated after BS were also associated with immune cells. Consistently, results in the validated dataset showed that the expression levels of these hub genes were increased in obese patients and mice, and decreased after BS. In conclusion, this study analysed the potential immune and inflammatory mechanisms of BS in three key metabolic tissues of obese patients, and revealed hub genes associated with immune cell infiltration, thus providing potential targets for obesity treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Kemin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Pengyuan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Jiewen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Hongyu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yanbing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Hai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Adipocyte</MedlineTA>
        <NlmUniqueID>101567863</NlmUniqueID>
        <ISSNLinking>2162-3945</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018925">Chemokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018121">Receptors, Cytokine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055633" MajorTopicYN="Y">Immune System Phenomena</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018121" MajorTopicYN="N">Receptors, Cytokine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">bariatric surgery</Keyword>
        <Keyword MajorTopicYN="N">bioinformatic analysis</Keyword>
        <Keyword MajorTopicYN="N">immune cell infiltration</Keyword>
        <Keyword MajorTopicYN="N">liver tissue</Keyword>
        <Keyword MajorTopicYN="N">skeletal muscle</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35412419</ArticleId>
        <ArticleId IdType="pmc">PMC9009953</ArticleId>
        <ArticleId IdType="doi">10.1080/21623945.2022.2060059</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO . Obesity and overweight.2021. Accessed09
November 2021; Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation>
        </Reference>
        <Reference>
          <Citation>Blüher . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadde KM, Martin CK, Berthoud H-R, et al. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7958889</ArticleId>
            <ArticleId IdType="pubmed">29301630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen NT, Varela. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27899816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arterburn DE, Courcoulas. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4707708</ArticleId>
            <ArticleId IdType="pubmed">25164369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3650620</ArticleId>
            <ArticleId IdType="pubmed">23675368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keshavjee SH, Schwenger KJP, Yadav J, et al. Factors affecting metabolic outcomes post bariatric surgery: Role of adipose tissue. J Clin Med. 2021;10(4):714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7916950</ArticleId>
            <ArticleId IdType="pubmed">33670215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefere S, Onghena L, Vanlander A, et al. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev. 2021;22(9):e13294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34002452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albers PH, Bojsen-Møller KN, Dirksen C, et al. Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol. 2015;309(5):R510–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26062634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen CJ, Murphy KE, Fernandez. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4717890</ArticleId>
            <ArticleId IdType="pubmed">26773015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu R, Nikolajczyk. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6653202</ArticleId>
            <ArticleId IdType="pubmed">31379820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huaizhu W, Ballantyne. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199705</ArticleId>
            <ArticleId IdType="pubmed">28045398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romeo Villarreal-Calderón J, Cuéllar RX, Ramos-González MR, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019:3940739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6925764</ArticleId>
            <ArticleId IdType="pubmed">31885787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song Y, Zhang J, Wang H, et al. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte. 2021;10(1):424–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8437528</ArticleId>
            <ArticleId IdType="pubmed">34506234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji Y, Lee H, Kaura S, et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules. 2021;11(11):1582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8615605</ArticleId>
            <ArticleId IdType="pubmed">34827579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goossens GH, Johan WEJ, Blaak. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33173188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>To Yeung Y, Aziz F, Guerrero-Castilla A, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449–1484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29589535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727–736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19543691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross SH, Cantrell. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411–433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6472684</ArticleId>
            <ArticleId IdType="pubmed">29677473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochumon S, Al Madhoun A, Al-Rashed F, et al. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance. Sci Rep. 2020;10(1):16364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7530670</ArticleId>
            <ArticleId IdType="pubmed">33004937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faramia J, Ostinelli G, Drolet-Labelle V, et al. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol. 2020;52:67–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32688292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mraz M, Haluzik. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25006217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzik TJ, Skiba DS, Touyz RM, et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res. 2017;113(9):1009–1023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5852626</ArticleId>
            <ArticleId IdType="pubmed">28838042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazankov K, Mark Dahl Jørgensen S, Louise Thomsen K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breuer DA, Pacheco MC, Washington MK, et al. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211–G224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7052570</ArticleId>
            <ArticleId IdType="pubmed">31709830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillon NJ, Bilan PJ, Fink LN, et al. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304(5):E453–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23277185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudrapatna S, Bhatt M, Wang K-W, et al. Obesity and muscle-macrophage crosstalk in humans and mice: a systematic review. Obes Rev. 2019;20(11):1572–1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31410961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newman AM, Long Liu C, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4739640</ArticleId>
            <ArticleId IdType="pubmed">25822800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying W, Wenxian F, Sok Lee Y, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8315273</ArticleId>
            <ArticleId IdType="pubmed">31836875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29319160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–4623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19837929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3425417</ArticleId>
            <ArticleId IdType="pubmed">22596049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing M, Jiang T, Tan L, et al. TYROBP in Alzheimer’s disease. Mol Neurobiol. 2015;51(2):820–826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25052481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindhu S, Kochumon S, Shenouda S, et al. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20(18):4658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6770648</ArticleId>
            <ArticleId IdType="pubmed">31546972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dommel S, Blüher. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state?
Int J Mol Sci. 2021;22(3):1500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7867366</ArticleId>
            <ArticleId IdType="pubmed">33540898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathews JA, Wurmbrand AP, Ribeiro L, et al. Induction of IL-17A precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D. Front Immunol. 2014;5:440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4164008</ArticleId>
            <ArticleId IdType="pubmed">25309539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rui X, Ming W, Liu S, et al. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) treg cells in ovarian cancer cells microenvironment. Cell Death Dis. 2021;12(1):22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7790820</ArticleId>
            <ArticleId IdType="pubmed">33414414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acín-Pérez R, Iborra S, Martí-Mateos Y, et al. Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity. Nat Metab. 2020;2(9):974–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8225238</ArticleId>
            <ArticleId IdType="pubmed">32943786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glowacka WK, Alberts P, Ouchida R, et al. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287(33):27691–27702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3431655</ArticleId>
            <ArticleId IdType="pubmed">22733818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 2011;17(11–12):1157–1167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3321803</ArticleId>
            <ArticleId IdType="pubmed">21738950</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35412419</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2162-397X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Adipocyte</Title>
          <ISOAbbreviation>Adipocyte</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Integrative analyses of hub genes and their association with immune infiltration in adipose tissue, liver tissue and skeletal muscle of obese patients after bariatric surgery.</ArticleTitle>
        <Pagination>
          <StartPage>190</StartPage>
          <EndPage>201</EndPage>
          <MedlinePgn>190-201</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21623945.2022.2060059</ELocationID>
        <Abstract>
          <AbstractText>Bariatric surgery (BS) is an effective treatment for obesity. Adipose tissue, liver tissue and skeletal muscle are important metabolic tissues. This study investigated hub genes and their association with immune infiltration in these metabolic tissues of obese patients after BS by bioinformatic analysis with Gene Expression Omnibus datasets. Differentially expressed genes (DEGs) were identified, and a protein-protein interaction network was constructed to identify hub genes. As a result, 121 common DEGs were identified and mainly enriched in cytokine-cytokine receptor interactions, chemokine signaling pathway, neutrophil activation and immune responses. Immune cell infiltration analysis showed that the abundance of M1 macrophages was significantly lower in adipose and liver tissue after BS (p&lt;0.05). Ten hub genes (TYROBP, TLR8, FGR, NCF2, HCK, CCL2, LAPTM5, MNDA and S100A9) that were all downregulated after BS were also associated with immune cells. Consistently, results in the validated dataset showed that the expression levels of these hub genes were increased in obese patients and mice, and decreased after BS. In conclusion, this study analysed the potential immune and inflammatory mechanisms of BS in three key metabolic tissues of obese patients, and revealed hub genes associated with immune cell infiltration, thus providing potential targets for obesity treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Kemin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Pengyuan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Jiewen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Hongyu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yanbing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Hai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Adipocyte</MedlineTA>
        <NlmUniqueID>101567863</NlmUniqueID>
        <ISSNLinking>2162-3945</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018925">Chemokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018121">Receptors, Cytokine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055633" MajorTopicYN="Y">Immune System Phenomena</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018121" MajorTopicYN="N">Receptors, Cytokine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">bariatric surgery</Keyword>
        <Keyword MajorTopicYN="N">bioinformatic analysis</Keyword>
        <Keyword MajorTopicYN="N">immune cell infiltration</Keyword>
        <Keyword MajorTopicYN="N">liver tissue</Keyword>
        <Keyword MajorTopicYN="N">skeletal muscle</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35412419</ArticleId>
        <ArticleId IdType="pmc">PMC9009953</ArticleId>
        <ArticleId IdType="doi">10.1080/21623945.2022.2060059</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO . Obesity and overweight.2021. Accessed09
November 2021; Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation>
        </Reference>
        <Reference>
          <Citation>Blüher . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadde KM, Martin CK, Berthoud H-R, et al. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7958889</ArticleId>
            <ArticleId IdType="pubmed">29301630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen NT, Varela. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27899816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arterburn DE, Courcoulas. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4707708</ArticleId>
            <ArticleId IdType="pubmed">25164369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3650620</ArticleId>
            <ArticleId IdType="pubmed">23675368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keshavjee SH, Schwenger KJP, Yadav J, et al. Factors affecting metabolic outcomes post bariatric surgery: Role of adipose tissue. J Clin Med. 2021;10(4):714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7916950</ArticleId>
            <ArticleId IdType="pubmed">33670215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefere S, Onghena L, Vanlander A, et al. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev. 2021;22(9):e13294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34002452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albers PH, Bojsen-Møller KN, Dirksen C, et al. Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol. 2015;309(5):R510–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26062634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen CJ, Murphy KE, Fernandez. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4717890</ArticleId>
            <ArticleId IdType="pubmed">26773015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu R, Nikolajczyk. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6653202</ArticleId>
            <ArticleId IdType="pubmed">31379820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huaizhu W, Ballantyne. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199705</ArticleId>
            <ArticleId IdType="pubmed">28045398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romeo Villarreal-Calderón J, Cuéllar RX, Ramos-González MR, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019:3940739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6925764</ArticleId>
            <ArticleId IdType="pubmed">31885787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song Y, Zhang J, Wang H, et al. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte. 2021;10(1):424–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8437528</ArticleId>
            <ArticleId IdType="pubmed">34506234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji Y, Lee H, Kaura S, et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules. 2021;11(11):1582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8615605</ArticleId>
            <ArticleId IdType="pubmed">34827579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goossens GH, Johan WEJ, Blaak. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33173188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>To Yeung Y, Aziz F, Guerrero-Castilla A, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449–1484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29589535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727–736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19543691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross SH, Cantrell. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411–433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6472684</ArticleId>
            <ArticleId IdType="pubmed">29677473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochumon S, Al Madhoun A, Al-Rashed F, et al. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance. Sci Rep. 2020;10(1):16364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7530670</ArticleId>
            <ArticleId IdType="pubmed">33004937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faramia J, Ostinelli G, Drolet-Labelle V, et al. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol. 2020;52:67–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32688292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mraz M, Haluzik. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25006217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzik TJ, Skiba DS, Touyz RM, et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res. 2017;113(9):1009–1023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5852626</ArticleId>
            <ArticleId IdType="pubmed">28838042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazankov K, Mark Dahl Jørgensen S, Louise Thomsen K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breuer DA, Pacheco MC, Washington MK, et al. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211–G224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7052570</ArticleId>
            <ArticleId IdType="pubmed">31709830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillon NJ, Bilan PJ, Fink LN, et al. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304(5):E453–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23277185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudrapatna S, Bhatt M, Wang K-W, et al. Obesity and muscle-macrophage crosstalk in humans and mice: a systematic review. Obes Rev. 2019;20(11):1572–1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31410961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newman AM, Long Liu C, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4739640</ArticleId>
            <ArticleId IdType="pubmed">25822800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying W, Wenxian F, Sok Lee Y, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8315273</ArticleId>
            <ArticleId IdType="pubmed">31836875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29319160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–4623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19837929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3425417</ArticleId>
            <ArticleId IdType="pubmed">22596049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing M, Jiang T, Tan L, et al. TYROBP in Alzheimer’s disease. Mol Neurobiol. 2015;51(2):820–826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25052481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindhu S, Kochumon S, Shenouda S, et al. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20(18):4658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6770648</ArticleId>
            <ArticleId IdType="pubmed">31546972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dommel S, Blüher. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state?
Int J Mol Sci. 2021;22(3):1500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7867366</ArticleId>
            <ArticleId IdType="pubmed">33540898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathews JA, Wurmbrand AP, Ribeiro L, et al. Induction of IL-17A precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D. Front Immunol. 2014;5:440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4164008</ArticleId>
            <ArticleId IdType="pubmed">25309539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rui X, Ming W, Liu S, et al. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) treg cells in ovarian cancer cells microenvironment. Cell Death Dis. 2021;12(1):22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7790820</ArticleId>
            <ArticleId IdType="pubmed">33414414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acín-Pérez R, Iborra S, Martí-Mateos Y, et al. Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity. Nat Metab. 2020;2(9):974–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8225238</ArticleId>
            <ArticleId IdType="pubmed">32943786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glowacka WK, Alberts P, Ouchida R, et al. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287(33):27691–27702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3431655</ArticleId>
            <ArticleId IdType="pubmed">22733818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 2011;17(11–12):1157–1167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3321803</ArticleId>
            <ArticleId IdType="pubmed">21738950</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35412419</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2162-397X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Adipocyte</Title>
          <ISOAbbreviation>Adipocyte</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Integrative analyses of hub genes and their association with immune infiltration in adipose tissue, liver tissue and skeletal muscle of obese patients after bariatric surgery.</ArticleTitle>
        <Pagination>
          <StartPage>190</StartPage>
          <EndPage>201</EndPage>
          <MedlinePgn>190-201</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21623945.2022.2060059</ELocationID>
        <Abstract>
          <AbstractText>Bariatric surgery (BS) is an effective treatment for obesity. Adipose tissue, liver tissue and skeletal muscle are important metabolic tissues. This study investigated hub genes and their association with immune infiltration in these metabolic tissues of obese patients after BS by bioinformatic analysis with Gene Expression Omnibus datasets. Differentially expressed genes (DEGs) were identified, and a protein-protein interaction network was constructed to identify hub genes. As a result, 121 common DEGs were identified and mainly enriched in cytokine-cytokine receptor interactions, chemokine signaling pathway, neutrophil activation and immune responses. Immune cell infiltration analysis showed that the abundance of M1 macrophages was significantly lower in adipose and liver tissue after BS (p&lt;0.05). Ten hub genes (TYROBP, TLR8, FGR, NCF2, HCK, CCL2, LAPTM5, MNDA and S100A9) that were all downregulated after BS were also associated with immune cells. Consistently, results in the validated dataset showed that the expression levels of these hub genes were increased in obese patients and mice, and decreased after BS. In conclusion, this study analysed the potential immune and inflammatory mechanisms of BS in three key metabolic tissues of obese patients, and revealed hub genes associated with immune cell infiltration, thus providing potential targets for obesity treatment.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Kemin</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Pengyuan</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jin</LastName>
            <ForeName>Jiewen</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Hongyu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yanbing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Hai</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Adipocyte</MedlineTA>
        <NlmUniqueID>101567863</NlmUniqueID>
        <ISSNLinking>2162-3945</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018925">Chemokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018121">Receptors, Cytokine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050110" MajorTopicYN="Y">Bariatric Surgery</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055633" MajorTopicYN="Y">Immune System Phenomena</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018121" MajorTopicYN="N">Receptors, Cytokine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">adipose tissue</Keyword>
        <Keyword MajorTopicYN="N">bariatric surgery</Keyword>
        <Keyword MajorTopicYN="N">bioinformatic analysis</Keyword>
        <Keyword MajorTopicYN="N">immune cell infiltration</Keyword>
        <Keyword MajorTopicYN="N">liver tissue</Keyword>
        <Keyword MajorTopicYN="N">skeletal muscle</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
          <Hour>12</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35412419</ArticleId>
        <ArticleId IdType="pmc">PMC9009953</ArticleId>
        <ArticleId IdType="doi">10.1080/21623945.2022.2060059</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>WHO . Obesity and overweight.2021. Accessed09
November 2021; Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.</Citation>
        </Reference>
        <Reference>
          <Citation>Blüher . Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadde KM, Martin CK, Berthoud H-R, et al. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7958889</ArticleId>
            <ArticleId IdType="pubmed">29301630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen NT, Varela. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27899816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arterburn DE, Courcoulas. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4707708</ArticleId>
            <ArticleId IdType="pubmed">25164369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3650620</ArticleId>
            <ArticleId IdType="pubmed">23675368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keshavjee SH, Schwenger KJP, Yadav J, et al. Factors affecting metabolic outcomes post bariatric surgery: Role of adipose tissue. J Clin Med. 2021;10(4):714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7916950</ArticleId>
            <ArticleId IdType="pubmed">33670215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefere S, Onghena L, Vanlander A, et al. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev. 2021;22(9):e13294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34002452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albers PH, Bojsen-Møller KN, Dirksen C, et al. Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol. 2015;309(5):R510–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26062634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersen CJ, Murphy KE, Fernandez. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4717890</ArticleId>
            <ArticleId IdType="pubmed">26773015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu R, Nikolajczyk. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6653202</ArticleId>
            <ArticleId IdType="pubmed">31379820</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huaizhu W, Ballantyne. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5199705</ArticleId>
            <ArticleId IdType="pubmed">28045398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romeo Villarreal-Calderón J, Cuéllar RX, Ramos-González MR, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019:3940739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6925764</ArticleId>
            <ArticleId IdType="pubmed">31885787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song Y, Zhang J, Wang H, et al. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte. 2021;10(1):424–434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8437528</ArticleId>
            <ArticleId IdType="pubmed">34506234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji Y, Lee H, Kaura S, et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules. 2021;11(11):1582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8615605</ArticleId>
            <ArticleId IdType="pubmed">34827579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goossens GH, Johan WEJ, Blaak. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33173188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>To Yeung Y, Aziz F, Guerrero-Castilla A, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449–1484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29589535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727–736.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19543691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross SH, Cantrell. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411–433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6472684</ArticleId>
            <ArticleId IdType="pubmed">29677473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kochumon S, Al Madhoun A, Al-Rashed F, et al. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance. Sci Rep. 2020;10(1):16364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7530670</ArticleId>
            <ArticleId IdType="pubmed">33004937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faramia J, Ostinelli G, Drolet-Labelle V, et al. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol. 2020;52:67–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32688292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mraz M, Haluzik. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25006217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzik TJ, Skiba DS, Touyz RM, et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res. 2017;113(9):1009–1023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5852626</ArticleId>
            <ArticleId IdType="pubmed">28838042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kazankov K, Mark Dahl Jørgensen S, Louise Thomsen K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breuer DA, Pacheco MC, Washington MK, et al. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211–G224.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7052570</ArticleId>
            <ArticleId IdType="pubmed">31709830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pillon NJ, Bilan PJ, Fink LN, et al. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304(5):E453–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23277185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rudrapatna S, Bhatt M, Wang K-W, et al. Obesity and muscle-macrophage crosstalk in humans and mice: a systematic review. Obes Rev. 2019;20(11):1572–1596.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31410961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newman AM, Long Liu C, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4739640</ArticleId>
            <ArticleId IdType="pubmed">25822800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ying W, Wenxian F, Sok Lee Y, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8315273</ArticleId>
            <ArticleId IdType="pubmed">31836875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29319160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–4623.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19837929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3425417</ArticleId>
            <ArticleId IdType="pubmed">22596049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing M, Jiang T, Tan L, et al. TYROBP in Alzheimer’s disease. Mol Neurobiol. 2015;51(2):820–826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25052481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindhu S, Kochumon S, Shenouda S, et al. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20(18):4658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6770648</ArticleId>
            <ArticleId IdType="pubmed">31546972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dommel S, Blüher. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state?
Int J Mol Sci. 2021;22(3):1500.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7867366</ArticleId>
            <ArticleId IdType="pubmed">33540898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mathews JA, Wurmbrand AP, Ribeiro L, et al. Induction of IL-17A precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D. Front Immunol. 2014;5:440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4164008</ArticleId>
            <ArticleId IdType="pubmed">25309539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rui X, Ming W, Liu S, et al. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) treg cells in ovarian cancer cells microenvironment. Cell Death Dis. 2021;12(1):22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7790820</ArticleId>
            <ArticleId IdType="pubmed">33414414</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acín-Pérez R, Iborra S, Martí-Mateos Y, et al. Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity. Nat Metab. 2020;2(9):974–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8225238</ArticleId>
            <ArticleId IdType="pubmed">32943786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glowacka WK, Alberts P, Ouchida R, et al. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287(33):27691–27702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3431655</ArticleId>
            <ArticleId IdType="pubmed">22733818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 2011;17(11–12):1157–1167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3321803</ArticleId>
            <ArticleId IdType="pubmed">21738950</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
